Company-Led Recall on Ozurdex Implant

Allergan Pharmaceuticals Ireland is further recalling batches due to the possibility that a single loose silicone particle of approximately 300 microns in diameter may become detached.

Class 4 Recall on Atropine Sulfate 3mg/10ml Solution For Injection In Pre-Filled Syringe

Aguettant Limited has informed the MHRA that there is an error in the Patient Information Leaflet (PIL) for batches of Atropine Sulfate 3mg/10ml Solution for injection in pre-filled syringe.

Class 2 Recall on Irbesartan Tab 300mg & Irbesartan Hydrochlorothiazide 300-25mg Tabs

Actavis Group PTC EHF is recalling the above batches from pharmacies as a precautionary measure due to possible contamination with N-nitrosodiethylamine (NDEA).

Class 4 Recall on Amoxicillin 500mg Capsules

Accord Healthcare Limited has informed us that that a change to the Patient Information Leaflet (PIL) for this product has not been implemented by the required timeline.

Class 2 Recall on Irbesartan 150mg & 300mg

Macleods Pharma UK Limited is recalling the above batches from pharmacies as a precautionary measure due to possible contamination with N‑nitrosodiethylamine (NDEA).

Class 2 Recall on Irbesartan

Actavis Group PTC EHF is recalling the below batches from pharmacies as a precautionary measure due to possible contamination with N‑nitrosodiethylamine (NDEA).

Class 2 Recall on Valsartan

Teva UK Limited and Mylan are recalling some Valsartan containing products including certain batches supplied by Teva UK Limited and all unexpired batches supplied by Mylan.

Company-led Drug Alert on Mitomycin-C Kyowa 10mg Powder for Solution for Injection

Kyowa Kirin Limited is recalling batch 6058517 Mitomycin-C Kyowa 10mg Powder for Solution for Injection. The batch is being recalled because an out of specification result for sub visible particles...
Showing 1 - 10 of 275 results.
Items per Page 10
of 28